Mesoblast's high-risk programs drive inflated valuation. Find out why MESO stock remains a "sell" as execution risks outweigh ...
Joby is making strides in eVTOL industry with strong progress in certification, manufacturing, and financing, potentially ...
The Motley Fool on MSN2d
Alnylam Delivers a Big Q4 Earnings BeatAlnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.
As the United States refocuses on domestic manufacturing and exports, QS Energy is delivering a Made in America solution that is designed, engineered, and built in U.S. facilities, reinforcing the ...
The three-year project announced breakthrough progress in finding cost-effective recycling paths for decommissioned blades.
5d
The Cool Down on MSNScientists make major progress on mission to create next-gen EV batteries: 'Will accelerate the commercialization'It's all part of worldwide research geared toward finding a lithium-ion battery alternative that uses cheaper parts with ...
MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...
Five University of Tennessee, Knoxville, faculty entrepreneurs, recipients of the university’s first Chancellor’s Innovation ...
Gevo, Inc. and Axens have formed a new strategic alliance to accelerate the development and commercialization of sustainable aviation fuel using the ethanol-to-jet pathway.
Find out the main objectives of the DOE Energy Quantum Leadership Act, introduced by Senators Dick Durbin and Steve Daines.
Elon Musk might not go ahead with his $97.4 billion bid for OpenAI’s nonprofit arm if the ChatGPT maker ceases its transition ...
Last year, we also signed a collaboration with Alvotech for the commercialization of their denosumab biosimilar in the U.S. and Europe. This latest collaboration with Henlius further progresses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results